Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.680
+0.170 (11.26%)
At close: Nov 6, 2026, 4:00 PM EST
1.523
-0.157 (-9.36%)
After-hours: Nov 6, 2026, 6:40 PM EST
Century Therapeutics Revenue
In the year 2025, Century Therapeutics had annual revenue of $109.16M with 1,556.76% growth. That makes Century Therapeutics the 21,994th largest company in the world by revenue and 3,231st in the United States.
Revenue (ttm)
$109.16M
Revenue Growth
+1,556.76%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
78
Market Cap
304.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.16M | 102.58M | 1,556.76% |
| Dec 31, 2024 | 6.59M | 4.35M | 194.81% |
| Dec 31, 2023 | 2.24M | -2.96M | -57.01% |
| Dec 31, 2022 | 5.20M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Fulcrum Therapeutics | 80.00M |
| Clinuvel Pharmaceuticals | 65.05M |
| Q32 Bio | 53.74M |
| Precision BioSciences | 45.04M |
| vTv Therapeutics | 36.84M |
| Arcturus Therapeutics Holdings | 29.37M |
| Ocugen | 4.78M |
| SAB Biotherapeutics | 114.70K |
IPSC News
- 25 days ago - Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 5 weeks ago - Century Therapeutics announces presentation of nonclinical data for CNTY-813 - TheFly
- 5 weeks ago - Century Therapeutics announces presentation of nonclinical data for CNTY-813 - TheFly
- 5 weeks ago - Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026 - GlobeNewsWire
- 1 month ago - Century Therapeutics Appoints Joseph Truitt to Board of Directors - GlobeNewsWire
- 2 months ago - Century Therapeutics reports Q2 EPS (17c), consensus (12c) - TheFly
- 2 months ago - Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Century Therapeutics Quarterly report: Q2 2026 - Filings